HOME >> MEDICINE >> NEWS
New compound holds promise for lupus and related diseases

Ann Arbor, MI A chemical cousin of anti-anxiety medications, such as Valium and Xanax, significantly reduces kidney inflammation in mice inbred to develop a disease resembling human systemic lupus erythematosus (SLE), researchers at the University of Michigan and the University of California-Berkeley have found.

Their research, described in the Oct. 16 issue of the Journal of Clinical Investigation, also reveals the novel mechanism by which the compound works, a discovery that could lead to safer and more effective new drugs for managing lupus and other autoimmune disorders.

"The best available therapies for lupus haven't changed for many, many years," says U-M's Gary D. Glick, Ph.D., one of the lead authors on the study. "It's a disease where the mechanisms that normally prevent the immune system from attacking components of one's own body are defective. Because we do not yet understand what triggers lupus, it has been very difficult to develop lupus-specific therapies."

In fact, the mainstays of treating lupus-related kidney inflammation---the major cause of illness and death in lupus patients---are drugs developed many years ago to kill cancer cells. When given to lupus patients, often in combination with immune-suppressing steroids, these cytotoxic agents kill immune cells. But because they lack specificity, they also kill healthy cells, resulting in serious side effects. What's more, they simply are not effective in some patients.

"Our compound, on the other hand, goes in and kills the bad players but leaves the good players alone," says Glick, a charter faculty member of the U-M Life Sciences Institute, who is the Werner E. Bachmann Collegiate Professor of Chemistry, and a professor of biological chemistry in the U-M Medical School.

The compound, a 1,4-benzodiazepine (designated as Bz-423), sets off a chain of events that results in apoptosis, a natural cell-suicide process by which the body rids itself of cells
'"/>

Contact: Sally Pobojewski
pobo@umich.edu
734-615-6912
University of Michigan Health System
16-Oct-2002


Page: 1 2 3

Related medicine news :

1. New compounds effective against Alzheimers disease onset and progression
2. Marijuana-like compounds may aid array of debiliating conditions ranging from Parkinsons to pain
3. New compounds show promise in fighting malaria and cancer
4. Blueberry compound shows promise of lowering cholesterol as effectively as drug
5. New class of compounds promises to revive failing hearts
6. New compound may act to keep thyroid activity in check
7. Study finds certain compounds in beer, wine effective in slowing breast cancer cell growth
8. Researchers testing compounds that may stop replication of T-cell leukemia virus
9. Cocoa froths with cancer-preventing compounds
10. Alcohol may compound its damaging effects through frontocerebellar circuitry
11. Synthetic marijuana compound reduces agitation, improves appetite in Alzheimers patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... ... September 03, 2020 , ... Access ... been promoted to the role of Vice President of Professional Services. True’s responsibilities ... the Professional Services team, and providing invaluable executive leadership throughout the company. ...
(Date:9/3/2020)... ... 03, 2020 , ... BluePearl Specialty and Emergency Pet ... (AFSP) annual signature event, Out of the Darkness (OOTD), which unites more than ... awareness of suicide prevention. To ensure Associate safety, BluePearl will not be participating ...
(Date:9/3/2020)... ARLINGTON, Va. (PRWEB) , ... September 03, 2020 ... ... enterprise imaging in radiology will be the focus of Fall 2020 Virtual Conference, ... by AuntMinnie.com. , "AI, Enterprise Imaging & Beyond" is the follow-up to ...
(Date:9/3/2020)... ... September 03, 2020 , ... The American Medical ... Wednesday, April 7, to Saturday, April 10, 2021, at Wynn Las Vegas. The ... a national trade show for non-invasive medical aesthetic practices that brings together owners, ...
(Date:9/3/2020)... ... September 03, 2020 , ... ... impairment, has announced the Best Memory Care Facilities in Louisville, KY. The guide ... and amenities. , According to the Alzheimer’s Association , 5.6 million ...
Breaking Medicine News(10 mins):
(Date:9/3/2020)... ... September 03, 2020 , ... Sickle Cell ... September by holding a series of events and supporting the events of member ... on the need for research and treatment of sickle cell disease. , “Individuals ...
(Date:9/3/2020)... , ... September 03, 2020 , ... ... Boulder’s Vance Lab ( https://www.colorado.edu/lab/vance/masks ), an aerosol and engineering lab, conducted tests ... better protection against the COVID-19 virus than many other masks. Q&J face masks ...
(Date:9/3/2020)... ... September 03, 2020 , ... Using Analysis of Variance — ... Sept. 17, 2020, 1:30 p.m.-3:00 p.m. EDT, https://www.fdanews.com/anova , How much would ... , While one can’t become one in 90 minutes, one can master a powerful ...
Breaking Medicine Technology:
Cached News: